BLAS
GIL EXTREMERA
Ikertzailea 2018-2019 tartean
Fundación Jiménez Díaz
Madrid, EspañaFundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628